End to End Scale Fully integrated, end-to-end support from technical assessment and strain development to production upscaling, tech transfer, and regulatory services, helping customers move from molecule concept to large-scale manufacturing in food, nutrition, agriculture, biomaterials, and biomining sectors.

Pilot Facility A newly launched pilot plant accelerates proof-of-concept and de-risks scale-up by validating processes before full production, appealing to startups, SPVs, and contract manufacturers seeking faster time-to-market and lower capital risk.

Global Footprint Dual-region footprint in Copenhagen and Davis enables EU–US collaboration, smoother tech transfer, and regulatory support for cross-border manufacturing programs and global customer reach.

Materials Partnerships Active collaboration with AMSilk to produce spider silk–based proteins demonstrates strength in advanced biomaterials; target biomaterials developers and specialty ingredient companies looking to scale high-value fermentation products.

Platform Momentum Powered by a platform licensed from Novonesis and supported by strong funding and growing revenue, 21st.BIO is well positioned to pursue multi-year manufacturing contracts, tech-transfer deals, and long-term supply agreements with mid-market to enterprise customers in the target sectors.